BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
13,420
-460 (-3.31%)
At close: Apr 2, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 116.7 billion as of April 2, 2026. Its market cap has decreased by -3.10% in one year.
Market Cap
116.70B
Enterprise Value
64.29B
Revenue
19.18B
Ranking
n/a
PE Ratio
17.18
Stock Price
13,420.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 116.70B, a decrease of -39.55%. That is a compound annual growth rate of -11.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 120.70B | -12.15% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuadMedicine | 151.56B |
| KoBioLabs | 115.54B |
| ViGenCell | 113.16B |
| NovMetaPharma | 112.88B |
| CORESTEMCHEMON | 112.23B |
| Quratis | 102.92B |
| TegoScience | 102.32B |
| CHA Vaccine Research Institute | 100.34B |